2 ASX shares that could EXPLODE when their M&A deals are done

A business can change overnight after a corporate buyout. Here are two stocks QVE analysts are excited about on that basis.

| More on:
impacts on newcrest share price by merger represented by two people bringing together jigsaw pieces against gold background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the biggest potential reasons for massive price movement in an ASX stock is mergers and acquisitions.

That's because, in an instant, the nature of the whole business can change.

If it's offloading an unprofitable activity, then the company can then concentrate on what it's good at. If it's bringing in a new business then it can immediately bring new products, customers and revenue.

So with that in mind, here are two ASX shares that the analyst at QV Equities are waiting with bated breath for corporate shenanigans:

The merger deal that could reduce debt and return capital to shareholders

TPG Telecom Ltd (ASX: TPG) shares seem like a perennial underachiever, but they've been going well in recent weeks.

"TPG Telecom (TPG) was up +14% after reporting a solid first half result and announcing it is in discussions with Vocus to divest its Enterprise, Government and Wholesale business at a valuation higher than the current share price implies," QVE analysts said in a memo to clients.

They are pinning their hopes on this deal coming to fruition, as it would put a further rocket under TPG shares.

"If there is a sale it would enable TPG to reduce debt, and potentially return capital to shareholders while focusing on its resilient and growing consumer business."

Last month, the Wilson Asset Management team was also bullish on TPG due to this potential transaction.

"The upgraded FY23 EBITDA guidance was pleasing and we look forward to receiving further updates around the proposed transaction in the coming months which may provide a further catalyst for a share price re-rating," it said in a note to its clients.

A bargain buy

Australian Clinical Labs Ltd (ASX: ACL) has been a poor investment even for long-term investors, with the stock now trading around 31% lower than its initial public offering (IPO) price.

Even last month, investors could only watch in horror.

"Australian Clinical Labs disappointingly declined -15% after reporting at its full year result that the recovery in underlying volumes are taking longer to recover to pre-COVID levels than anticipated," said the QVE team.

"The fall in COVID-related revenues will result in little earnings growth in FY2024."

However, it does currently pay out a nice fully franked 5% dividend yield and has a transformative deal awaiting regulatory approval.

"ACL's proposed merger with pathology peer Healius Ltd (ASX: HLS) remains under consideration by the ACCC, if it goes ahead it will deliver significant synergies."

In fact, the QVE team took advantage of the recent stock price weakness.

"We increased our position in ACL, as we think its longer-term prospects look strong."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Tpg Telecom. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man sits smiling at a computer showing graphs
Broker Notes

Morgans names more of the best ASX 200 shares to buy in December

These ASX 200 shares have been given the thumbs up by analysts at Morgans in December.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Broker Notes

Morgans names the best ASX 200 shares to buy in December

Morgans is expecting strong returns from these top ASX 200 shares over the next 12 months.

Read more »

A man sits at a desk holding a small replica house in his hand, upset at the sale of his property.
Real Estate Shares

The 2 ASX real estate shares everyone's piling on to right now

Property stocks have been rocketing the past few weeks, and these companies are the ones investors are flocking to.

Read more »

Miner and company person analysing results of a mining company.
Resources Shares

Buy or sell? Brokers argue best play for ASX 200 iron ore share, up 30% in 2 months

There are conflicting opinions among the experts.

Read more »

A person sitting at a desk smiling and looking at a computer.
Investing Strategies

'Ahead of expectations': Why this ASX stock could make you smile in a few years

Sometimes the stock price doesn't reflect the business performance. This is when long-term investors can pounce.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

'Double-digit earnings growth': 2 fast-rising ASX shares not too late to buy

Get on these stocks before all their potential is realised, say Celeste analysts. So what are you waiting for?!

Read more »